AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Preventing the Recurrence of Acute Pancreatitis by Alcohol and Smoking Cessation

RecruitingNAAges 18 Years - 80 YearsAllUniversity of Pecs
💬

In plain words

What the trial is, and whether it could suit you

Recurrence of acute pancreatitis (AP) is often facilitated by regular alcohol consumption and smoking. An applied lifestyle intervention focusing on the cessation of alcohol consumption and smoking might prevent the recurrence of AP. REAPPEAR Study is a randomized controlled trial and a cohort study focusing on the efficacy of the lifestyle intervention and the effect of quitting alcohol and smoking respectively.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion criteria: * Patient hospitalized with alcohol-induced AP (defined by the revised Atlanta criteria 38) * Every day smoker (defined as an adult patient who smoked at least 100 cigarettes in his or her lifetime, and now smokes on a daily basis; as per the CDC definition), with at least 1-year history of smoking * Aged 18-80 years * Provided written informed consent * Willing to participate in the intervention in every three months Exclusion criteria: * Possible etiologies for AP other than alcohol (eg. gallstone-related, hypertriglyceridemia above 11.5 mM 40-42, hypercalcemia, viral infection) if the etiological cannot be terminated during the index admission (lack of same admission cholecystectomy, familiar hypertrygliceridemia) and cases with combined etiological factors will be excluded * Untreated, decompensated or severe mMajor psychiatric illnesses (e.g. schizophrenia, bipolar disorder, dementia) * Currently taking part in a smoking cessation program * Undergoing active or palliative treatment for malignancy * Pregnancy, breastfeeding * Life expectancy is less than two years * Didn't agreed to participate * Other
💊

What it tests

  • Standard intervention only
  • Standard intervention plus repeated intervention
📍

Where

1 site
Institute for Translational Medicine, University of Pécs
Pécs, Hungary
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy